Journal of Medicinal Chemistry p. 4443 - 4453 (2009)
Update date:2022-08-04
Topics:
Liu, Weiguo
Liu, Kun
Wood, Harold B.
McCann, Margaret E.
Doebber, Thomas W.
Chang, Ching H.
Akiyama, Taro E.
Einstein, Monica
Berger, Joel P.
Meinke, Peter T.
A series of 3-acylindole-1-benzylcarboxylic acids were designed and synthesized while searching for a PPARγ modulator with additional moderate intrinsic PPARα agonistic activity. 2-[3-[[3-(4-Chlorobenzoyl)-2-methyl- 6-(trifluoromethoxy)-1H-indol-1-yl]methyl]phenoxy]-(2R)-butanoic acid (12d) was identified as such an agent which demonstrated potent efficacy in lowering both glucose and lipids in multiple animal models with significantly attenuated side effects such as fluid retention and heart weight gain associated with PPARγ full agonists. The moderate PPARα activity of 12d not only contributed to the agent's ability to manage lipid profiles but also appears to have potentiated its PPARγ efficacy in lowering glucose levels in preclinical diabetic animal models.
View MoreContact:+86-13666670345
Address:Agricultural Development Zone, Haining, Jiaxing, Zhejiang
Weifang Yukai Chemical Co.,Ltd.
website:http://www.yukaichem.com/en.html
Contact:+86-536-8865336
Address:binhai economic development zone,262737 shangdong,china
Contact:+86-021-6989-5597
Address:No.80 Yichuan Rd., Putuo District,Shanghai,P.R.China
Contact:+86-577-65618087-605
Address:Room 402, Unit 4 Xinhu Bldg. Waitan Ruian City, Zhejiang China.
Contact:86-512-69362780,69362785
Address:No.69 Weixin Road,Weiting Town,Suzhou Industrial Park
Doi:10.1002/anie.200352464
(2004)Doi:10.1039/P19960002213
(1996)Doi:10.1039/c39860000198
(1986)Doi:10.1021/ja056741n
(2006)Doi:10.1002/hlca.200390339
(2003)Doi:10.1007/BF00673330
()